Haemolytic Uraemic Syndrome and Its Relation to Metastatic Prostate Adenocarcinoma: A Case Report
Munoz-Unceta N*, Espinosa P, Manneh R, Castellano D and Paz-Ares L
Medical Oncology Department of Hospital Universitario 12 de Octubre, Madrid, Spain
- *Corresponding Author:
- Muñoz-Unceta N
Medical Oncology Department of
12 de Octubre, Madrid, Spain
Tel: +60 3-8921 5555
E-mail: [email protected]
Received Date: July 15, 2016; Accepted Date: August 18, 2016; Published Date: August 22, 2016
Citation: Munoz-Unceta N, Espinosa P, Manneh R, Castellano D, Paz-Ares L (2016) Haemolytic Uraemic Syndrome and Its Relation to Metastatic Prostate Adenocarcinoma: A Case Report. Adv Oncol Res Treat 1:109. doi: 10.4172/2572-5025.1000109
Copyright: © 2016 Muñoz-Unceta N, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Haemolytic Uraemic Syndrome (HUS) has been rarely related to prostate cancer. The few cases reported in the literature show a better prognosis with the implementation of oncologic treatment. Its pathogenesis is unknown and has never been described as a consequence of treatment with bicalutamide. At the presented case this association couldn’t be dismissed due to its temporal relationship, so surgical castration was carried out. it is important to recognize signs and symptoms of HUS on time because an early intervention is related to a better outcome.